Amphastar Pharmaceuticals (AMPH) News Today $28.19 -0.27 (-0.95%) As of 01:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Fox Run Management L.L.C. Makes New $688,000 Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Fox Run Management L.L.C. acquired a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 18,526 shares of the company's stock, valued at approximately $688,000. Other hedge fMarch 25 at 4:56 AM | marketbeat.comIntech Investment Management LLC Purchases 29,167 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Intech Investment Management LLC boosted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 224.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,156 sharesMarch 23 at 4:26 AM | marketbeat.comPiper Sandler Issues Pessimistic Forecast for Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock PriceMarch 23 at 1:33 AM | americanbankingnews.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Cut to $32.00 by Analysts at Piper SandlerPiper Sandler reduced their price target on Amphastar Pharmaceuticals from $36.00 to $32.00 and set a "neutral" rating for the company in a research report on Friday.March 22 at 11:40 AM | marketbeat.comBoston Partners Purchases New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Boston Partners acquired a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 426,636 shares of the company's stock, valued atMarch 22 at 4:45 AM | marketbeat.comAmphastar price target lowered to $32 from $36 at Piper SandlerMarch 21, 2025 | markets.businessinsider.comAmundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Amundi grew its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 193.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,583 shares of the company's stock after buying an additionMarch 20, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. decreased its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 19.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 67,367March 19, 2025 | marketbeat.comVictory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Victory Capital Management Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 71.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 63,387 shares of thMarch 18, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 1-Year Low - Should You Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month Low - Should You Sell?March 13, 2025 | marketbeat.comQ4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals StocksMarch 13, 2025 | msn.comWealthfront Advisers LLC Invests $9.27 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Wealthfront Advisers LLC acquired a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 249,605 shares of the company's stock, valueMarch 13, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Trevi Therapeutics (TRVI) and Cross Country Healthcare (CCRN)March 10, 2025 | markets.businessinsider.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells $116,521.74 in StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) CFO William J. Peters sold 4,231 shares of the company's stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $27.54, for a total transaction of $116,521.74. Following the transaction, the chief financial officer now directly owns 97,363 shares of the company's stock, valued at $2,681,377.02. This trade represents a 4.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.March 7, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare ConferenceMarch 6, 2025 | finanznachrichten.deAmphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 52-Week Low - Time to Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 1-Year Low - What's Next?March 1, 2025 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Receives a Hold from Piper SandlerMarch 1, 2025 | markets.businessinsider.comAmphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses ExpectationsMarch 1, 2025 | finance.yahoo.comIs Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?March 1, 2025 | msn.comIllumine Investment Management LLC Makes New $633,000 Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Illumine Investment Management LLC bought a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 17,049 shares of the compaMarch 1, 2025 | marketbeat.comAmphastar price target lowered to $36 from $44 at BofAMarch 1, 2025 | markets.businessinsider.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Releases Earnings Results, Misses Expectations By $0.18 EPSAmphastar Pharmaceuticals (NASDAQ:AMPH - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.18). Amphastar Pharmaceuticals had a return on equity of 26.44% and a net margin of 21.80%.February 28, 2025 | marketbeat.comSpecialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive HeadwindsFebruary 28, 2025 | benzinga.comAmphastar: Earnings Miss, Margins DropFebruary 28, 2025 | fool.comAmphastar Pharmaceuticals misses Q4 estimates, shares tumbleFebruary 28, 2025 | za.investing.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%February 28, 2025 | finance.yahoo.comAmphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comAmphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year periodFebruary 27, 2025 | finance.yahoo.comD.A. Davidson & CO. Makes New $417,000 Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)D.A. Davidson & CO. purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 11,244 sharFebruary 26, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC reduced its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 42.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,064 shares oFebruary 25, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 3.3% - Should You Buy?Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Up 3.3% - What's Next?February 24, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month Low - Should You Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month Low - Here's WhyFebruary 20, 2025 | marketbeat.comAmphastar Pharmaceuticals: A Gradual StrategyFebruary 19, 2025 | seekingalpha.comAmphastar Pharmaceuticals (AMPH) Projected to Post Quarterly Earnings on WednesdayAmphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing earnings before the market opens on Wednesday, February 26.February 19, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Drop in Short InterestAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) was the target of a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 4,120,000 shares, a decrease of 10.4% from the January 15th total of 4,600,000 shares. Based on an average trading volume of 545,700 shares, the short-interest ratio is currently 7.5 days. Currently, 11.5% of the shares of the company are short sold.February 17, 2025 | marketbeat.comAmphastar stock hits 52-week low at $31.54 amid market challengesFebruary 13, 2025 | msn.comPolaris Capital Management LLC Purchases Shares of 24,500 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Polaris Capital Management LLC purchased a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 24,500 shares of the companyFebruary 11, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month Low - Should You Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month Low - Time to Sell?February 10, 2025 | marketbeat.comPiper Sandler Downgrades Amphastar Pharmaceuticals (AMPH)February 5, 2025 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Here's What HappenedAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Time to Sell?February 4, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Neutral Rating by Piper SandlerPiper Sandler lowered Amphastar Pharmaceuticals from an "overweight" rating to a "neutral" rating and lowered their target price for the company from $66.00 to $36.00 in a report on Tuesday.February 4, 2025 | marketbeat.comAmphastar downgraded to Neutral from Overweight at Piper SandlerFebruary 4, 2025 | markets.businessinsider.comAmphastar Pharmaceuticals (AMPH) Gets a Hold from Bank of America SecuritiesFebruary 4, 2025 | markets.businessinsider.comPiper Sandler cuts Amphastar stock rating, slashes price targetFebruary 4, 2025 | msn.comBoston Trust Walden Corp Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Boston Trust Walden Corp grew its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 81.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 978,920 shares of the company's stock afterFebruary 4, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 52-Week Low - Here's What HappenedAmphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month Low - Here's What HappenedFebruary 3, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 10.3% in JanuaryAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 4,820,000 shares, an increase of 10.3% from the December 31st total of 4,370,000 shares. Based on an average trading volume of 476,100 shares, the short-interest ratio is currently 10.1 days. Currently, 13.5% of the company's stock are sold short.February 1, 2025 | marketbeat.comPacer Advisors Inc. Has $50.14 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Pacer Advisors Inc. grew its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 51,977.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,350,368 shares of the company's sJanuary 28, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Arrowhead Pharmaceuticals (ARWR)January 23, 2025 | markets.businessinsider.comAmphastar reports Q4 adjusted EPS 55c, consensus 50cJanuary 23, 2025 | markets.businessinsider.com Remove Ads Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address AMPH Media Mentions By Week AMPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼0.620.63▲Average Medical News Sentiment AMPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼94▲AMPH Articles Average Week Remove Ads Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VRNA News Today GRFS News Today ELAN News Today ADMA News Today PTCT News Today RNA News Today ACLX News Today OGN News Today ZLAB News Today RARE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMPH Stock Free AMPH Stock Alerts